Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-08-15 00:00:00 ET · period of report 2023-08-11 · accession 0001822629-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-15 | 2023-08-15 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | M - OptEx | $29.00 | +11.6K | 365.0K | +3% | +$336.9K |
| DM | 2023-08-15 | 2023-08-11+ | ANIP | Lalwani Nikhil | Pres, CEO, Dir | S - Sale+OE | $58.32 | -68.3K | 353.4K | -16% | -$3.98M |
| D | 2023-08-15 | 2023-08-15 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | M - OptEx | $29.00 | -11.6K | 168.0K | -6% | -$336.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-15 | M | A | 11,616 | $29.00 | 365,006 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-11 | S | D | 56,666 | $57.75 | 353,390 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-15 | S | D | 11,616 | $61.13 | 353,390 | D | — | — | (F1) Reflects the weighted average price of sales on August 15, 2023. The shares were sold in multiple transactions at prices ranging from $60.68 to $61.87, inclusive. |
| 4 | Derivative | Stock Option (right to buy) | 2023-08-15 | M | D | 11,616 | $29.00 | 168,027 | D | $29.00 · — to 2030-09-08 | 11,616 Common Stock | (F2) 25% of the total options vested on each of September 8, 2021 and September 8, 2022. 25% of the total options will vest on each of September 8, 2023 and September 8, 2024. |